Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657148 · ClinicalTrials.gov registry record
Immediate Postpartum Nexplanon Placement in Opioid Dependent Women
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 200
- Enrollment target
NCT02657148 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 200 participants.
The verdict
NCT02657148 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The investigators have designed a single site, Phase IV open label, prospective observational clinical trial to compare the effect of immediate postpartum Nexplanon placement (IPP) versus standard postpartum contraceptive care (control) on consistent contraceptive use and rapid repeat pregnancy at 12 months postpartum in 200 opioid dependent (OD) women.
Interventions
- DRUG Nexplanon (etonogestrel contraceptive implant)
- DRUG Standard postpartum contraceptive care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02657148
The ClinicalTrials.gov registry entry for NCT02657148 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nexplanon (etonogestrel contraceptive implant) is the first listed.
NCT02657148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02657148 about?
NCT02657148 is a clinical study titled "Immediate Postpartum Nexplanon Placement in Opioid Dependent Women". The investigators have designed a single site, Phase IV open label, prospective observational clinical trial to compare the effect of immediate postpartum Nexplanon placement (IPP) versus standard postpartum contraceptive care (control) on consistent contraceptive use and rapid repeat pregnancy at 1...
What is the current status of trial NCT02657148?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2016-05. Estimated completion is 2018-08.
What interventions are being tested in trial NCT02657148?
The interventions under investigation include: Nexplanon (etonogestrel contraceptive implant) (DRUG), Standard postpartum contraceptive care (DRUG).
Who is sponsoring clinical trial NCT02657148?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.